CN1131542A - Whole turtle shark capsule - Google Patents
Whole turtle shark capsule Download PDFInfo
- Publication number
- CN1131542A CN1131542A CN 95113312 CN95113312A CN1131542A CN 1131542 A CN1131542 A CN 1131542A CN 95113312 CN95113312 CN 95113312 CN 95113312 A CN95113312 A CN 95113312A CN 1131542 A CN1131542 A CN 1131542A
- Authority
- CN
- China
- Prior art keywords
- shark
- capsule
- chemotherapy
- whole
- turtle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
A capsule for improving immunity and regeneration power of leucocyte, protecting thymus, and increasing engalfing power of macrophage and transform activity of lymphocyte is prepared from soft-shelled turtle, tortoise, placenta and shark, and features stable quality and no contraindication. It is suitable for various chronic infectious diseases such as hepatitis and organism function recovery of patient after operation, radiotherapy and chemicotherapy.
Description
The present invention relates to a kind of Chinese medicine of combined with chemotherapy malignant tumor.
At present, take often seeing of chemotherapeutic treatment for the patient who suffers from malignant tumor, but chemotherapeutic treatment is bigger to the toxic and side effects of human body, it not only makes patient produce reactions such as appetite decline, vomiting, stomachache, limb fiber crops, insomnia, and main be that it can make patient's leukopenia and cause immunologic hypofunction.
The objective of the invention is: the Chinese medicine that a kind of combined with chemotherapy malignant tumor is provided--whole turtle shark capsule, it can alleviate the toxic and side effects that chemotherapy produces patient significantly, improve body's immunological function, the leukocyte increasing regeneration capacity makes chemotherapy process smoothly, carry out up hill and dale.
The component and the proportioning of whole turtle shark capsule of the present invention are:
(1). Trionyx sinensis (Wiegmann) 1.6--2.4;
(2). QUANGUI 0.8--1.2;
(3). Placenta Hominis 1.6--2.4;
(4). shark 0.8--1.2.
Gross weight is 6 Unit Weights.
To live earlier Trionyx sinensis Wiegmann, the Testudinis that lives of method for making taken out internal organs, cleans after drying, simultaneously with the shark clean dry, again will above-mentioned three medicines and Placenta Hominis mixes, be ground into 100 order powder behind the vacuum drying, and in the sterile chamber, incapsulate.
The present invention can human body immunity improving function, the leukocyte increasing regeneration capacity can be used for recovering body function after various infectious chronic diseases, perioperatively and cancer patient radiotherapy, the chemotherapy such as hepatitis.
The invention will be further described below in conjunction with embodiment:
Embodiment: a kind of whole turtle shark capsule, adopt following component and proportioning:
(1). Trionyx sinensis (Wiegmann) 2;
(2). QUANGUI 1;
(3). Placenta Hominis 2;
(4). shark 1.
Gross weight is 6 Unit Weights.
Adopt following technology: the Trionyx sinensis Wiegmann that will live earlier, the Testudinis that lives are taken out internal organs, clean after drying, simultaneously with the shark clean dry, again will above-mentioned three medicines and Placenta Hominis mixes, be ground into 100 order powder behind the vacuum drying, and in the sterile chamber, incapsulate.
Trionyx sinensis Wiegmann, Testudinis, Placenta Hominis are famous and precious medicinal organisms in this whole turtle shark capsule, contain rich in protein, animal glue phosphorus, ferrum, iodine and multivitamin, can suppress connective tissue proliferation, improve lymhocyte transformation rate, prolong the antibody life period, prevent the cancerous cell sudden change and promote hemopoietic function.According to scientific research personnel such as the U.S. Miami Universities shark serum and extract are put into human cancer cell's culture fluid again, all as a result cancerous cell are placed in the fatal position very soon, and they think that it is secrets that they do not give birth to cancer that shark serum and body contain a large amount of vitamin A.
The present invention has carried out clinical research to the following three groups patients that suffer from malignant tumor of digestive tract:
(1). whole turtle shark capsule combined with chemotherapy group (40 example), i.e. patient's the 8th day employing FMV chemotherapy regimen, oral whole turtle shark capsule simultaneously after operation;
(2). simple chemotherapy group (30 example), promptly only carry out chemotherapy, do not take whole turtle shark capsule;
(3). simple Trionyx sinensis (Wiegmann) shark group (30 example), promptly only take whole turtle shark capsule, do not carry out chemotherapy.
The result:
(1). the caused toxic and side effects of whole turtle shark capsule combined with chemotherapy group patient is lighter, and late 7--10 of time days of occurring than simple chemotherapy group patient's toxic and side effects; Simple whole turtle shark capsule group patient's appetite obviously increases, the calm sleep.
(2). after finishing the course of treatment, whole turtle shark capsule combined with chemotherapy group patient's weight average has increased by 1.05 ± 0.25kg; Simple chemotherapy group patient's the 1.20 ± 0.24kg that lost weight; Simple whole turtle shark capsule group patient's weight increase 1.40 ± 0.22kg.
(3). whole turtle shark capsule combined with chemotherapy group patient WBC 〉=3.2 * 10 in the course of treatment
9/ L all finishes chemotherapy whole process; The simple WBC of chemotherapy group patient in the course of treatment is lower than 28 examples that have before treating, and 8 routine patients wherein arranged because of being lower than 3.2 * 10
9/ L and interrupt chemotherapy, mortality is 26.6%.
(4). macrophage phagocytic percentage rate and phagocytic index are before treatment after whole turtle shark capsule combined with chemotherapy group and the simple whole turtle shark capsule group patient medication; The contrast macrophage phagocytic function significantly descends before and after the simple chemotherapy group patient medication.
(5). whole turtle shark capsule combined with chemotherapy group patient controls back lymphocyte transformation function and obviously improves; And simple chemotherapy group changes not quite.
(6). before whole turtle shark capsule combined with chemotherapy group patient whole blood contrast viscosity is controlled is 7.02 ± 1.36, drops to 6.21 ± 1.25 after controlling, and notable difference is arranged, and other group then changes little.
Above-mentioned clinical research proves; combined with chemotherapy malignant tumor of digestive tract of the present invention; can obviously reduce the toxic and side effects of chemotherapeutics; with said preparation combined with chemotherapy group patient; each systemic-function does not have obvious disorder and obstacle; appetite and sleep be good in the treatment, weight increase, with simple chemotherapy group relatively; there were significant differences; protection body hemopoietic function, whole turtle shark capsule combined with chemotherapy group patient leukocyte does not have obvious decline, and simple chemotherapy group chemotherapy mortality reaches 26.6%; two groups of leukocyte average contrast differences are remarkable; whole turtle shark capsule is wanted immune organ thymus to the protection body weight for humans simultaneously, strengthens the macrophage phagocytic ability, and raising LTA etc. all has remarkable effect.Said preparation medicine matter is stable, no incompatibility, and future is widely used.
Claims (1)
1. whole turtle shark capsule, its component and proportioning are: (1). Trionyx sinensis (Wiegmann) 1.6--2.4; (2). QUANGUI 0.8--1.2; (3). Placenta Hominis 1.6--2.4; (4). shark 0.8--1.2.Gross weight is 6 Unit Weights.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 95113312 CN1131542A (en) | 1995-10-19 | 1995-10-19 | Whole turtle shark capsule |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 95113312 CN1131542A (en) | 1995-10-19 | 1995-10-19 | Whole turtle shark capsule |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1131542A true CN1131542A (en) | 1996-09-25 |
Family
ID=5079928
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 95113312 Pending CN1131542A (en) | 1995-10-19 | 1995-10-19 | Whole turtle shark capsule |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1131542A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1084203C (en) * | 1999-04-26 | 2002-05-08 | 刘祖文 | Health-care tortoise-turtle-pollen food and its preparing process |
-
1995
- 1995-10-19 CN CN 95113312 patent/CN1131542A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1084203C (en) * | 1999-04-26 | 2002-05-08 | 刘祖文 | Health-care tortoise-turtle-pollen food and its preparing process |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
McCredie et al. | Increased granulocyte collection with the blood cell separator and the addition of etiocholanolone and hydroxyethyl starch | |
CN102712503A (en) | An immunoactivation blood perfusion filter for the treatment of malignant tumors | |
US5186931A (en) | Composition and method for supporting bone marrow transplantation | |
Perotti et al. | Feasibility and safety of a new technique of extracorporeal photochemotherapy: experience of 240 procedures | |
CN1057445C (en) | Method for preparing anticancer bioactive peptide preparation | |
CN116173175A (en) | Preparation method of blood perfusion filler for treating immunodeficiency-induced tumors | |
CN1131542A (en) | Whole turtle shark capsule | |
CN101703497B (en) | Application of Chlorogenic acid in preparing drug having protection and restoration functions on spleen hematopoietic stem cell injuries | |
CN101212963B (en) | The use of chlorogenic acid in the manufacture of medicaments for increasing the effect of bone marrow cells | |
CN101695485B (en) | Use of chlorogenic acid in preparing medicament for treating thrombocytopenia and anemia | |
CN107397765A (en) | A kind of sporoderm-broken ganoderma spores extract and its extracting method and application | |
Menichella et al. | Low-dose cyclophosphamide in combination with cisplatin or epirubicin plus rhG-CSF allows adequate collection of PBSC for autotransplantation during adjuvant therapy for high-risk cancer | |
CN101053588A (en) | Preparation method for compound arabinogalactan film coated tablets | |
CN1053197C (en) | Anti-cancer active matter Huogu mushroom essence and its extracting process | |
CN110548133A (en) | use of hemoglobin and hemoglobin derivatives for the preparation of injectable pharmaceutical formulations for enhancing immune function | |
CN1086296C (en) | Compound donkey-hide gelatin preparation for preventing arrest of bone marrow in chemotherapy and radiotherapy and preparing process thereof | |
CN1091029A (en) | The peach colloidal solution of raise immunity and raising hemogram | |
CN1771984B (en) | New use of extracellular polysaccharide of halophilous aphanothece | |
CN1611249A (en) | Antisenescent longevity powder | |
CN110151987B (en) | Application of symmetrical IgG and composition thereof in preparation of medicines for treating and preventing tumors | |
CN1283272C (en) | Complex anticancer medicine and preparing method thereof | |
CN1273173C (en) | New use of medicine for preventing and treating radiative damage | |
CN1196263A (en) | Chinese medicinal preparation for treating leukemia | |
CN1057208C (en) | Process of preparing medicine for treating anemia and promoting leukoblastosis by rhodiola root extract | |
CN1421227A (en) | Medicine for preventing and treating radiative damage |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C01 | Deemed withdrawal of patent application (patent law 1993) | ||
WD01 | Invention patent application deemed withdrawn after publication |